Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30) | Zendy

Gijs W.D. Landman | Zendy; Peter R. van Dijk | Zendy; Iefke Drion | Zendy; Kornelis J. J. van Hateren | Zendy; Joachim Struck | Zendy; Klaas H. Groenier | Zendy; Rijk O. B. Gans | Zendy; Henk J.G. Bilo | Zendy; Stephan J. L. Bakker | Zendy; Nanne Kleefstra | Zendy

Open Access

Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30)

Author(s) -

Gijs W.D. Landman,

Peter R. van Dijk,

Iefke Drion,

Kornelis J. J. van Hateren,

Joachim Struck,

Klaas H. Groenier,

Rijk O. B. Gans,

Henk J.G. Bilo,

Stephan J. L. Bakker,

Nanne Kleefstra

Publication year - 2013

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc13-1852

Subject(s) - medicine , albuminuria , hazard ratio , diabetes mellitus , creatinine , type 2 diabetes , proportional hazards model , interquartile range , endocrinology , confidence interval

The midregional fragment of proadrenomedullin (MR-proADM) is a marker of endothelial dysfunction and has been associated with a variety of diseases. Our aim was to investigate whether MR-proADM is associated with new-onset albuminuria and cardiovascular (CV) and all-cause mortality in patients with type 2 diabetes treated in primary care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research